Cognition Therapeutics to present at conference

Cognition Therapeutics, Inc. is set to participate in the Needham Virtual Healthcare Conference. As a clinical-stage company focused on developing drugs for neurodegenerative diseases, Cognition Therapeutics will likely provide an update on its therapeutic pipeline. The presentation is an opportunity for the company to engage with potential investors and partners, highlighting its progress in drug development and its strategic vision for treating cognitive disorders. This conference appearance is key for showcasing its innovation.